Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxing Xue

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|April 11, 2023
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editingXiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Protein & Cell|June 7, 2023
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editorYinghui Wei, Meiling Zhang, Jing Hu, et al.
Nature Biotechnology|August 11, 2022
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effectsHuawei Tong, Jia Huang, Qingquan Xiao, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|April 11, 2023
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editingXiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Protein & Cell|June 7, 2023
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editorYinghui Wei, Meiling Zhang, Jing Hu, et al.
Nature Biotechnology|August 11, 2022
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effectsHuawei Tong, Jia Huang, Qingquan Xiao, et al.
Pageof 2